-
venBio is a life sciences investment firm that partners with industry leaders to build game-changing medicines and technologies, with a focus on novel therapeutics for unmet medical needs.
Latest News
-
2021
12AUGArtiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply
posted by admin in Latest NewsArtiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility for NK Cell Therapy Pipeline Development and Clinical Supply...
Read More -
2021
24JUNElevation Oncology Announces Pricing of Initial Public Offering
posted by admin in Latest NewsElevation Oncology Announces Pricing of Initial Public Offering...
Read More -
2021
15JUNRayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer
posted by admin in Latest NewsRayzeBio Secures $108 Million Series C Financing to Drive Forward Its Pipeline of Targeted Radiopharmaceuticals for Cancer...
Read More -
2021
03JUNvenBio Raises $550 Million Venture Capital Fund Focused on Life Sciences
posted by admin in Latest NewsvenBio Raises $550 Million Venture Capital Fund Focused on Life Sciences...
Read More